{
  "query": "death cause infection antiviral",
  "studies": {
    "protocolSection": [
      {
        "identificationModule": {
          "nctId": "NCT04340544",
          "briefTitle": "Hydroxychloroquine for the Treatment of Mild COVID-19 Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-04-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-10-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "COVID-19"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 17,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04621071",
          "briefTitle": "Efficacy of Probiotics in Reducing Duration and Symptoms of COVID-19"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-01-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-10-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "COVID-19"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 17,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05195866",
          "briefTitle": "CRP for Respiratory Diagnosis in Kyrgyz Pediatric Practice"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-11-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-04-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Antibiotic Resistance", "Respiratory Tract Infections", "Pediatric Infectious Disease", "CRP"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1204,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Months",
          "maximumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05894603",
          "briefTitle": "Effectiveness and Safety of New Oral Antivirals for COVID-19"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-08-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "COVID-19"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 211,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01482767",
          "briefTitle": "Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV Infection"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-04"
          },
          "completionDateStruct": {
            "date": "2015-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["HIV Infections", "Hepatitis C"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 262,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04979884",
          "briefTitle": "Safety and Effectiveness of Cyclosporin in the Management of COVID19 ARDS Patients in Alexandria University Hospital"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-01-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-12-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["COVID-19 Acute Respiratory Distress Syndrome", "Cytokine Release Syndrome", "Pulmonary Fibrosis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 66,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06031272",
          "briefTitle": "Pausing Antiretroviral Treatment Under Structured Evaluation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-05-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-04-05",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "HIV-1-infection"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 32,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04824222",
          "briefTitle": "The Impact of Fecal Microbiota Transplantation as an Immunomodulation on the Risk Reduction of COVID-19 Disease Progression With Escalating Cytokine Storm and Inflammatory Parameters"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-04",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2022-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Covid19"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 366,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03367624",
          "briefTitle": "Epidemiology of Post-influenza Bacterial Pneumonia Due to a Panton-Valentine Leukocidin Positive Staphylococcus Aureus"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-10-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-03",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Influenza", "Staphylococcus Aureus Pneumonia", "PV Leukocidin"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 35,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04382625",
          "briefTitle": "Hydroxychloroquine in SARS-CoV-2 (COVID-19) Pneumonia Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-10",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2022-06-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["SARS-CoV-2 Pneumonia", "COVID-19"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00950755",
          "briefTitle": "Study of Iodine 131 Anti B1 Antibody for 1st or 2nd Relapsed Indolent B-Cell Lymphomas or B-Cell Lymphomas That Have Transformed to a More Aggressive Histology"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "1998-06"
          },
          "completionDateStruct": {
            "date": "2011-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lymphoma, Non-Hodgkin"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 41,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02964871",
          "briefTitle": "Rapid Assessment of and Prophylaxis for Influenza in Dwellers of Long-term Care Facilities"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-10-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Influenza, Human", "Pneumonia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00000697",
          "briefTitle": "A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Who Cannot Use Ganciclovir"
        },
        "statusModule": {
          "startDateStruct": {},
          "completionDateStruct": {}
        },
        "conditionsModule": {
          "conditions": ["Cytomegalovirus Retinitis", "HIV Infections"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "13 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00933335",
          "briefTitle": "Study of Safety and Efficacy of a Sequential Regimen Consisting of Three Cycles of Fludarabine Followed by Tositumomab and Iodine I 131 Tositumomab"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "1998-08"
          },
          "completionDateStruct": {
            "date": "2010-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lymphoma, Non-Hodgkin"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 38,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03612973",
          "briefTitle": "Changes in Liver Fibrosis, Lipid Profile and Insulin Resistance in HCV Patients Who Received Antiviral Therapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-06-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-09-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Hepatitis c"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 80,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02124044",
          "briefTitle": "Safety, Tolerability, and Efficacy of Asunaprevir and Daclatasvir in Subjects Coinfected With HIV-HCV"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-02"
          },
          "completionDateStruct": {
            "date": "2016-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "HIV-HCV"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04730206",
          "briefTitle": "The DAWN Antivirals Trial for Ambulatory COVID-19 Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-06-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-07-13",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Covid19", "SARS-CoV Infection"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 44,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06653569",
          "briefTitle": "Efficacy of Baloxavir Against Influenza in Hospitalized Patients: the INFLUENT Study (INpatients InFLUENza Treatment)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-12",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-09",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Influenza Disease; Flu"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 484,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02972723",
          "briefTitle": "Metformin Therapy in HCV Infection"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-03"
          },
          "completionDateStruct": {
            "date": "2011-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Hepatitis C Infection"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 16,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00447902",
          "briefTitle": "Safety and Antiviral Activity of TPV in HCV and/or HBV HIV Coinfected Patients TDM Randomised Pilot Evaluation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-03"
          },
          "completionDateStruct": {}
        },
        "conditionsModule": {
          "conditions": "HIV Infections"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 11,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04341688",
          "briefTitle": "A Clinical Trial of Gargling Agents in Reducing Intraoral Viral Load Among COVID-19 Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-12-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2022-07-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Covid-19"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05498779",
          "briefTitle": "Ablation of Hepatocellular Carcinoma: a Nationwide Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-06-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-09-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Hepatocellular Carcinoma", "Ablation", "Hepatitis C"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 490,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "100 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01231620",
          "briefTitle": "A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With Influenza"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-01-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2015-03-18",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Influenza, Human"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 626,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05713279",
          "briefTitle": "Study of Flonoltinib Maleate Tablets in the Treatment of Severe Novel Coronavirus (COVID-19) Infection"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-01-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-11-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "COVID-19"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 66,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02836925",
          "briefTitle": "Ledipasvir+Sofosbuvir and Sofosbuvir+Velpatasvir for Pts With Indolent Bcell Lymphoma Associated With HCV Infection"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-03"
          },
          "completionDateStruct": {
            "date": "2022-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Indolent B-cell Lymphoma", "Hepatitis C"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04325893",
          "briefTitle": "Hydroxychloroquine Versus Placebo in COVID-19 Patients at Risk for Severe Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-04-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-06-18",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Coronavirus"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 259,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04474340",
          "briefTitle": "COVID-19 Convalescent Plasma Treatment in SARS-CoV-2 Infected Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-05-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-12-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Moderate COVID-19 Pneumonia, Severe COVID-19 Pneumonia", "Pneumonia, Viral"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 300,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "15 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06855004",
          "briefTitle": "Prospective Cohort of Patients With Fibrosing Interstitial Lung Disease Admitted for Acute Respiratory Failure"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-01-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2030-10-28",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Fibrosing Interstitial Lung Disease"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 250,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01964755",
          "briefTitle": "Chemotherapy for Relapsed Epstein Barr Virus Associated Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-04-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-06-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Epstein Barr Virus Associated Non Hodgkin's Lymphoma", "Epstein Barr Virus Associated Hodgkin's Lymphoma", "Post-Transplant Lymphoproliferative Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 6,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06674148",
          "briefTitle": "A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Qifangfeixian Granules in the Treatment of Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-10-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-06-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Interstitial Lung Disease", "Qifangfeixian Granules"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 124,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04910269",
          "briefTitle": "Outpatient Treatment With Anti-Coronavirus Immunoglobulin"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-08-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-08-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["COVID", "SARS-CoV2 Infection", "Covid19"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 820,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04310865",
          "briefTitle": "Yinhu Qingwen Granula for the Treatment of Severe CoVID-19"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-11",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2023-04",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["COVID-19", "Severe Pneumonia", "Chinese Medicine"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 116,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02178592",
          "briefTitle": "Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-01-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-03-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Infection, Human Immunodeficiency Virus", "HIV Infections"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 113,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05671315",
          "briefTitle": "A Prospective Study to Evaluate Peginterferon in Reducing the Incidence of HCC in CHB Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-07-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-04",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Chronic Hepatitis B", "Intermediate to High Risk of HCC"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 267,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04649515",
          "briefTitle": "Efficacy and Safety of TY027, a Treatment for COVID-19, in Humans"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-12-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-03-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Coronavirus Disease-2019 (COVID-19)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 17,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "21 Years",
          "maximumAge": "100 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04682873",
          "briefTitle": "A Clinical Study to Assess the Efficacy and Safety of AmizonÂ® Max in the Treatment of Moderate Covid-19, Caused by the SARS-CoV-2 Virus"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-05-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-03-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Covid-19 Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 592,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04322344",
          "briefTitle": "Escin in Patients With Covid-19 Infection"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-03-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-12-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Coronavirus Infections"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 120,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05210101",
          "briefTitle": "A Safety and Tolerability Study of Sotrovimab (VIR-7831) Prophylaxis Against COVID-19 in Immunocompromised Individuals"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-02-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-02-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "SARS CoV 2 Infection"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 93,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04720612",
          "briefTitle": "COVID-19 Immunologic Antiviral Therapy With Omalizumab"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-10-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-12-16",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Covid19"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04515446",
          "briefTitle": "Quantification of Viral Load in the Upper Respiratory Tract in Patients Treated With Olsetamivir for Influenza"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-02-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-03-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Flu"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 18,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00006154",
          "briefTitle": "A Study to Evaluate the Use of a Protease Inhibitor and of Interleukin-2 (IL-2) in the Treatment of Early HIV Infection"
        },
        "statusModule": {
          "startDateStruct": {},
          "completionDateStruct": {}
        },
        "conditionsModule": {
          "conditions": "HIV Infections"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 165,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04365101",
          "briefTitle": "Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-05-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Coronavirus", "Coronavirus Infection", "Severe Acute Respiratory Syndrome Coronavirus 2", "Pneumonia", "Pneumonia, Viral", "Lung Diseases", "Respiratory Tract Disease", "Respiratory Tract Infections", "Coronaviridae Infections", "Nidovirales Infections", "RNA Virus Infections", "Virus Disease", "Immunologic Disease", "ARDS", "Immunologic Factors", "Physiological Effects of Drugs", "Antiviral Agents", "Anti-infective Agents", "Analgesics", "Antimetabolites, Antineoplastic"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 86,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04492501",
          "briefTitle": "Investigational Treatments for COVID-19 in Tertiary Care Hospital of Pakistan"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-04-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-07-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Covid19", "Cytokine Release Syndrome", "Critical Illness", "ARDS"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 600,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "90 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00854581",
          "briefTitle": "Zidovudine, Interferon Alfa-2b, PEG-Interferon Alfa-2b in Patients With HTLV-I Associated Adult T-Cell Leukemia/Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-11"
          },
          "completionDateStruct": {
            "date": "2011-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Lymphoma", "Precancerous/Nonmalignant Condition"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 13,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04316377",
          "briefTitle": "Norwegian Coronavirus Disease 2019 Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-03-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-03-03",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Corona Virus Infection"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 53,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01195181",
          "briefTitle": "Different PEG-interferon and Ribavirin Schedules for Chronic Hepatitis C in the Real Clinical Practice."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2005-09"
          },
          "completionDateStruct": {
            "date": "2010-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Hepatitis C Virus", "Chronic Liver Disease", "Viral Hepatitis", "Therapeutic Uses", "Antiviral Agents"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 506,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04429763",
          "briefTitle": "Safety and Efficacy of Mesenchymal Stem Cells in the Management of Severe COVID-19 Pneumonia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-07",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2020-11",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "COVID-19"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "79 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04437693",
          "briefTitle": "Post Exposure Prophylaxis in Healthcare Workers Exposed to COVID-19 Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-08-31",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2021-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "COVID 19"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 500,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02352389",
          "briefTitle": "A Pilot Study of Influenza Viruses Isolated From Immunocompromised Children and Adolescents"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-03-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-12-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Influenza, Human"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 16,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "21 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04577482",
          "briefTitle": "Study of Oral Glecaprevir/Pibrentasvir Tablets in Participants Aged 12 Years or Older With Chronic Hepatitis C to Assess Sustained Virological Response"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-10-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-09-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hepatitis C Virus (HCV)"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 42,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04840199",
          "briefTitle": "A Study to Evaluate the Anti-inflammatory Effects of Letermovir (Prevymis) in Adults With Human Immunodeficiency Virus (HIV)-1 and Asymptomatic Cytomegalovirus (CMV) Who Are on Suppressive Antiretroviral Therapy, Plus Its Effect on Chronic Inflammation, HIV Persistence and Other Clinical Outcomes."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-04-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-11-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["HIV Infections", "Cytomegalovirus", "CMV"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 44,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03775798",
          "briefTitle": "Incidence of de Novo Hepatocellular Carcinoma After Antiviral Agents for HCV."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-05-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-01-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Hepatitis C", "Cirrhosis", "Antiviral Drug Adverse Reaction"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 2200,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04323592",
          "briefTitle": "Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-03-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-05-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Severe Acute Respiratory Syndrome (SARS) Pneumonia", "Coronavirus Infections", "ARDS, Human"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 173,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01566695",
          "briefTitle": "The Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo and Best Supportive Care in Subjects With Red Blood Cell (RBC) Transfusion-Dependent Anemia and Thrombocytopenia Due to International Prognostic Scoring System (IPSS) Low Risk Myelodysplastic Syndrome (MDS)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-04-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-12-21",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Myelodysplastic Syndrome"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 216,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03478033",
          "briefTitle": "Rifampicin vs Rifabutin in HIV/AIDS Patients Combined With Tuberculosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-04-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Tuberculosis, Pulmonary", "AIDS"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 230,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02057757",
          "briefTitle": "Nitazoxanide Versus Placebo for the Treatment of Hospitalized Subjects With Severe Acute Respiratory Illness"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-02"
          },
          "completionDateStruct": {
            "date": "2018-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Severe Acute Respiratory Illness"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 260,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Months"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00996593",
          "briefTitle": "Study of Iodine-131 Anti-B1 Antibody for Patients With Non Hodgkin's Lymphoma Who Have Previously Received Rituximab"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "1998-07"
          },
          "completionDateStruct": {
            "date": "2009-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lymphoma, Non-Hodgkin"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 43,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06349655",
          "briefTitle": "The Real-world Clinical Study of Azvudine Tablets in the Treatment of COVID-19"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-12-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-03-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["COVID-19", "Azvudine"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 32864,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02037282",
          "briefTitle": "A Phase 1, Open Label, Ascending Dose Cohort Study of the Pharmacokinetics of Anti-Influenza Hyperimmune Intravenous Immunoglobulin in Healthy Subjects"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-01-03"
          },
          "completionDateStruct": {
            "date": "2014-12-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Influenza", "Flu"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04366973",
          "briefTitle": "A Study Describing the Care Cascade and Effectiveness and Safety of Glecaprevir/Pibrentasvir in Adult Participants With Hepatitis C Virus in French Addiction Centers"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-05-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-12-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hepatitis C Virus (HCV)"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 95,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04415073",
          "briefTitle": "A Phase 2 Study to Evaluate Axatilimab for Hospitalized Participants With Respiratory Involvement Secondary to COVID-19"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-05-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-07-13",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Coronavirus", "COVID", "ARDS", "Cytokine Storm", "Cytokine Release Syndrome"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02842827",
          "briefTitle": "A Study of Bomedemstat (IMG-7289/MK-3543) With and Without ATRA, in Participants With Advanced Myeloid Malignancies (IMG-7289-CTP-101/MK-3543-001)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-10-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-10-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukemia", "Myelodysplastic Syndrome"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 45,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04319172",
          "briefTitle": "Multicentric Study of Coronavirus Disease 2019 (COVID-2019) in Solid Organ Transplant Recipients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-03-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-12-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Transplant Recipient", "Infections, Coronavirus"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 488,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03502694",
          "briefTitle": "Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Oral Lumicitabine Regimens in Hospitalized Adult Participants Infected With Human Metapneumovirus"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-11-05",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2020-10-28",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Metapneumovirus"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04321993",
          "briefTitle": "Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-04-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-04",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "COVID-19"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 363,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04479202",
          "briefTitle": "The Effect of Berberine on Intestinal Function and Inflammatory Mediators in Severe Patients With Covid-19"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-02-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-04-23",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Berberine", "COVID-19"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 76,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06199934",
          "briefTitle": "Effectiveness of BNT162b2 Formulations Using State Vaccine Registry and Insurance Claims Data"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-09-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-07-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["SARS-CoV-2", "COVID-19 Vaccines"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 19853610,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04952350",
          "briefTitle": "Atorvastatin for Reduction of 28-day Mortality in COVID-19: RCT"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-08-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-04",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Covid19", "SARS-CoV2 Infection", "COVID-19 Pneumonia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 220,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02735707",
          "briefTitle": "Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-04-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-02",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Community-acquired Pneumonia, Influenza, COVID-19"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20000,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04889040",
          "briefTitle": "Study to Evaluate the Effects of RO7496998 (AT-527) in Non-Hospitalized Adult and Adolescent Participants With Mild or Moderate COVID-19"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-04-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-12-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "COVID-19"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 216,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05705167",
          "briefTitle": "Plitidepsin Versus Control in Immunocompromised Adult Participants With Symptomatic COVID-19 Requiring Hospital Care (NEREIDA)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-04-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-04-19",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "COVID-19"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 37,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00001100",
          "briefTitle": "A Phase III Study to Evaluate the Safety and Efficacy of Ganciclovir (Dihydroxypropoxymethyl Guanine [DHPG]) Treatment of Symptomatic Central Nervous System (CNS) Congenital Cytomegalovirus (CMV) Infections."
        },
        "statusModule": {
          "startDateStruct": {},
          "completionDateStruct": {
            "date": "2005-11"
          }
        },
        "conditionsModule": {
          "conditions": "Cytomegalovirus Infections"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 130
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "1 Month"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00006164",
          "briefTitle": "Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2000-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2009-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Chronic Hepatitis c", "Cirrhosis, Liver", "Fibrosis, Liver", "Hepatic Cirrhosis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1050,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02506933",
          "briefTitle": "Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV and Undergoing Donor Hematopoietic Cell Transplant"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-11-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-06-09",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "Acute Lymphoblastic Leukemia in Remission", "Acute Myeloid Leukemia in Remission", "Chronic Lymphocytic Leukemia", "Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "Cytomegaloviral Infection", "Hodgkin Lymphoma", "Lymphadenopathy", "Lymphoblastic Lymphoma", "Myelodysplastic Syndrome", "Myelofibrosis", "Myeloproliferative Neoplasm", "Non-Hodgkin Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 102,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00546715",
          "briefTitle": "A Single Ascending Dose Study of Daclatasvir (BMS-790052) in Hepatitis C Virus Infected Subjects"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-11"
          },
          "completionDateStruct": {
            "date": "2008-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Hepatitis C"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 95,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "49 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01408537",
          "briefTitle": "Immunogenicity and Safety of Inactivated Vero Cell Derived Japanese Encephalitis Vaccine in Thai Children"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-05"
          },
          "completionDateStruct": {
            "date": "2012-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Encephalitis, Japanese B"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 152,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "1 Year",
          "maximumAge": "3 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02889094",
          "briefTitle": "French HIV-HBV Cohort"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-10"
          },
          "completionDateStruct": {
            "date": "2018-09",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Hepatitis B", "HIV", "Liver Cirrhosis", "End Stage Liver Disease"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 152,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04371822",
          "briefTitle": "Efficacy of Sunlight Activated Synthetic Porphyrin in COVID-19 Infected Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-08",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2020-11",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "COVID-19"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 56,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02935673",
          "briefTitle": "Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Orally Administered Lumicitabine Regimens in Adult Participants Hospitalized With Respiratory Syncytial Virus"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-10-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-07-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Respiratory Syncytial Viruses"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 49,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03212833",
          "briefTitle": "Impact of Insulin Resistance on Therapeutic Response for Oral Treatment of Chronic Hepatitis C Virus Infection"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-05-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-12-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Hepatitis C"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06991907",
          "briefTitle": "PD-1 Inhibitor Combined With 125I Seed Implantation for Hepatocellular Carcinoma's Extrahepatic Metastasis: Efficacy and Safety"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-01-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-03-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["HCC - Hepatocellular Carcinoma", "125I Seeds Implantation"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 80,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04935684",
          "briefTitle": "Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-12-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Leukemia in Remission", "Myelodysplastic Syndromes", "Myeloproliferative Syndrome", "Hodgkin Lymphoma", "Lymphoma, Non-Hodgkin", "Myeloma", "Chronic Lymphocytic Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 150,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01573000",
          "briefTitle": "A Randomized Study of Iodine-131 Anti-b1 Antibody Versus Anti-b1 Antibody in Chemotherapy-relapsed/Refractory Low-grade or Transformed Low-grade Non-Hodgkin's Lymphoma (NHL)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "1998-09"
          },
          "completionDateStruct": {
            "date": "2010-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lymphoma, Non-Hodgkin"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 78,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04358068",
          "briefTitle": "Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-05-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-07-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["COVID-19", "SARS-CoV 2"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02507882",
          "briefTitle": "Impact of IL-28B rs12979860 and rs4803217 Gene Polymorphisms Associated With miRNAs Deregulation on HCV-related Hepatocellular Carcinoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-01"
          },
          "completionDateStruct": {}
        },
        "conditionsModule": {
          "conditions": "HCV Infection ( Genotype 4)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 405,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "10 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04257656",
          "briefTitle": "A Trial of Remdesivir in Adults With Severe COVID-19"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-02-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-04-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["COVID-19", "Remdesivir", "SARS-CoV-2"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 237,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02155985",
          "briefTitle": "Modulation of Immune Activation by Aspirin"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-08"
          },
          "completionDateStruct": {
            "date": "2015-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "HIV-1 Infection"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 121,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04473053",
          "briefTitle": "DEFINE - Evaluating Therapies for COVID-19"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-07-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-04-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "COVID-19"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 71,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01404312",
          "briefTitle": "Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-05-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-11-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Tuberculosis", "HIV Infections"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 3000,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "13 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00099632",
          "briefTitle": "Comparison of Three Anti-HIV Regimens to Prevent Nevirapine Resistance in Women Who Take Nevirapine During Pregnancy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-03"
          },
          "completionDateStruct": {
            "date": "2011-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "HIV Infections"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 484,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "13 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04391309",
          "briefTitle": "COVID-19 and Anti-CD14 Treatment Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-04-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-02-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Coronavirus Disease 2019 (COVID-19)", "Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 49,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05999435",
          "briefTitle": "Study of LAU-7b for the Treatment of Long COVID in Adults"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-11-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-11-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Long COVID"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 272,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02344290",
          "briefTitle": "Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-03-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-08-21",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["HIV", "Cardiovascular Diseases"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 7769,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03734393",
          "briefTitle": "HOPE in Action Trial of HIV+ Deceased Donor Liver Transplants for HIV+ Recipients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-01-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-10-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Hiv"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 80,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00989664",
          "briefTitle": "Pivotal Study of Iodine I 131 Tositumomab for Chemotherapy-refractory Low-grade or Transformed Low-grade B-cell Non-Hodgkin's Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "1996-11"
          },
          "completionDateStruct": {
            "date": "2008-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lymphoma, Non-Hodgkin"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04328714",
          "briefTitle": "Interferon Î³-Primed Mesenchymal Stromal Cells as Prophylaxis for Acute Graft v Host Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-12-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-08",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Leukemia", "Myelodysplastic Syndromes"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 45,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "1 Year"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01599325",
          "briefTitle": "Study of Azacitidine to Evaluate Safety and Effectiveness for Chinese Patients With Higher Risk Myelodysplastic Syndrome"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-07-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-03-13",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Myelodysplastic Syndrome (MDS)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 72,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04690933",
          "briefTitle": "AntiCMV molÃ©cules Monitoring in Real-life in Stem Cell Recipients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-09-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-11-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Hematopoietic Stem Cell Transplantation", "Cytomegalovirus Infections", "Antivirals", "Antiviral Drug Resistance"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 400,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04405310",
          "briefTitle": "Convalescent Plasma of Covid-19 to Treat SARS-COV-2 a Randomized Doble Blind 2 Center Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-05-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-12-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "SARS Pneumonia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 42,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04439916",
          "briefTitle": "Breakthrough CMV Lung Transplant -Multicentre"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-01-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Cytomegalovirus Infections"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      }
    ],
    "protocolSection.1": [
      {
        "identificationModule": {
          "nctId": "NCT05587894",
          "briefTitle": "OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients: a Randomized Factorial Controlled Strategy Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-04-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-05",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["COVID-19", "Immunodeficiency"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 256,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05780268",
          "briefTitle": "LY3819253 (LY-CoV555) for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-08-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-02-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "COVID-19"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 314,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05089968",
          "briefTitle": "Ventilation Associated Pneumonia and Covid-19"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-01-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-01-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["SARS-CoV2 Infection", "Ventilator Associated Pneumonia", "Ards", "COVID-19"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 268,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06817889",
          "briefTitle": "Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-12-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-11-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Hematopoietic and Lymphatic System Neoplasm", "Autoimmune Disease", "Respiratory Syncytial Virus Infection"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05712096",
          "briefTitle": "eVusheld Assessment reaL wORld Effectiveness in Israel Clalit Health Services"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-03-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-05-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["SARS-CoV-2", "COVID-19"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 4000,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01248715",
          "briefTitle": "Rapid Empiric Treatment With Oseltamivir Study (RETOS)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-11"
          },
          "completionDateStruct": {
            "date": "2016-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Influenza", "Pneumonia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1107,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06469424",
          "briefTitle": "An Active Surveillance, Post-Authorization Study to Characterize the Safety of Tofacitinib in Patients With Moderately to Severely Active Ulcerative Colitis in the Real-World Setting Using Data From the United Registries for Clinical Assessment and Research (UR-CARE) in the European Union (EU)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-01-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-03-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 104,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04812496",
          "briefTitle": "Tenofovir-DF Versus Hydroxychloroquine in the Treatment of Hospitalized Patients With COVID-19 (TEDHICOV)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-03-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-01-15",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Covid19", "SARS-CoV Infection", "Tenofovir"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 100,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04483960",
          "briefTitle": "Australasian COVID-19 Trial (ASCOT) ADAptive Platform Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-07-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "SARS-CoV-2 Infection (COVID-19)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2200,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04708340",
          "briefTitle": "Tolerability and Efficacy of RJX in Patients With COVID-19"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-03-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-02",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["COVID-19", "Acute Respiratory Distress Syndrome", "SARS-CoV-2", "Hypoxemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 237,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05780424",
          "briefTitle": "BRII-196/BRII-198 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-12-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-10-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "COVID-19"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 353,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04970719",
          "briefTitle": "Baricitinib in Hospitalized Covid-19 Patients With Diabetes Mellitus"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-07-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "COVID-19 Pneumonia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05268419",
          "briefTitle": "Efficacy and Safety of Ethanol Inhalation on COVID-19 Treatment (a Clinical Trial Study)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-09-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-12-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Clinical Infection", "Outcome", "Morality"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 150,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "12 Years",
          "maximumAge": "77 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05705141",
          "briefTitle": "The Effect of Metabolic Syndrome on Antiviral Response in People With Chronic Hepatitis B"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-04",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Hepatitis b"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 1000,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02474199",
          "briefTitle": "Donor Alloantigen Reactive Tregs (darTregs) for Calcineurin Inhibitor (CNI) Reduction"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-06-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-12-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Liver Transplant Recipient", "Living Donor (of the Respective Liver Transplant Recipient)"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 15,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06160128",
          "briefTitle": "Clinical Outcomes and Pharmacotherapy Effectiveness in the VA Health Care System (COPE-VA)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-09-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-09-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["COVID-19, SARS-CoV-2 Infection", "RSV", "Influenza"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 400000,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05780463",
          "briefTitle": "MP0420 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-06-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-06-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "COVID-19"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 485,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05346484",
          "briefTitle": "A Study of CF33-hNIS (VAXINIA), an Oncolytic Virus, as Monotherapy or in Combination With Pembrolizumab in Adults With Metastatic or Advanced Solid Tumors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-05-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-11",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Solid Tumor", "Solid Carcinoma", "Solid Tumor, Adult", "Metastatic Cancer", "Advanced Solid Tumor", "Cholangiocarcinoma", "Bile Duct Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 100,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04242433",
          "briefTitle": "HCV RAS Testing in Public Health Programs"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-07-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-08",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Hepatitis C", "Public Health", "Direct Acting Antiviral Agents", "Resistance Associated Substitutions"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 200,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04330508",
          "briefTitle": "Effects of Direct-acting Antiviral Agents on HCV Cognitive Function, and Depression in HCV Related Cirrhosis: A Prospective Clinical Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-03-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-12-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Depression in Chronic Hepatitis C"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 385,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01592799",
          "briefTitle": "Study on the Burden of Influenza-related Hospitalizations and Emergency Room (ER) Visits in Children in Spain"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-11-23"
          },
          "completionDateStruct": {
            "date": "2011-05-23",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Influenza"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 501,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "15 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03753074",
          "briefTitle": "Effectiveness of TAF in Reducing Clinical Events in CHB Patients Beyond Treatment Indications by Current Guidelines"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-02-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2031-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Hepatitis b"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 780,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05421325",
          "briefTitle": "Efficacy of QBKPN Site-Specific Immunomodulator in Improving Innate Immune Function & Reducing Respiratory Tract Infection in Older Adults"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-04-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-02",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Immune Deficiency"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 72,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06339892",
          "briefTitle": "HCMV Breakthrough Infections During Letermovir Prophylaxis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-01-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-03",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Cytomegalovirus Infections", "Cytomegalovirus Viremia", "Hematopoietic Stem Cell Transplantation"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 140,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05545319",
          "briefTitle": "A Study to Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People With Weakened Immune Systems or at Increased Risk for Poor Outcomes Who Are Hospitalized Due to Severe COVID-19"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-12-13",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2024-01-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)", "Coronavirus Disease 2019 (COVID-19)", "Immunocompromised", "Hospitalization", "Child, Hospitalized"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07013474",
          "briefTitle": "A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-07-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-05-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "COVID-19 Infection"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 300,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06180590",
          "briefTitle": "The Efficacy of Vosevi in Treating DAA-experienced Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-02-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-02-28",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Chronic Hepatitis C", "Medication Reaction"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 200,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "20 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03274427",
          "briefTitle": "Treatment of Intermediate-stage Hepatocellular Carcinoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-07-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-07",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "HCC"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 300,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05276297",
          "briefTitle": "A Study on the Safety, Efficacy and Immune Response Following Sequential Treatment With an Anti-sense Oligonucleotide Against Chronic Hepatitis B (CHB) and Chronic Hepatitis B Targeted Immunotherapy (CHB-TI) in CHB Patients Receiving Nucleos(t)Ide Analogue (NA) Therapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-03-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-08-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hepatitis B, Chronic"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 174,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03520660",
          "briefTitle": "People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-10-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2032-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Diabetes Mellitus", "Hepatitis C, Chronic", "Cardiovascular Diseases"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 121,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "120 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03851991",
          "briefTitle": "The Efficacy and Safety of Arbidol in Reducing the Frequency of AECOPD."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-08-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-10-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "COPD Patients"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 351,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00298233",
          "briefTitle": "High-Dose Versus Standard-Dose Oseltamivir to Treat Severe Influenza and Avian Influenza"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-02"
          },
          "completionDateStruct": {
            "date": "2010-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Influenza", "Avian Influenza", "Severe Influenza"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 326,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "1 Year"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04577378",
          "briefTitle": "Efficacy and Safety of Drug Combination Therapy of Isotretinoin and Some Antifungal Drugs as A Potential Aerosol Therapy for COVID-19 : An Innovative Therapeutic Approach COVID-19"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-10-20",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2020-11-20",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Covid19"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 45,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "15 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01257204",
          "briefTitle": "Study in Genotype 2 or 3 Patients With Chronic Hepatitis Virus Infection"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-12"
          },
          "completionDateStruct": {
            "date": "2012-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hepatitis C Virus"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 196,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03587467",
          "briefTitle": "Study on Gut Microbiota in Chronic HBV Infected Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-12-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-12-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Chronic Hepatitis B Infection", "Healthy"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 90,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02639559",
          "briefTitle": "Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With Advanced Hematological Malignancies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-03-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-04-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myelogenous Leukemia", "Acute Lymphoblastic Leukemia", "Chronic Myelogenous Leukemia", "Non-Hodgkin's Lymphoma", "Non-Hodgkin Lymphoma", "Hodgkin Disease", "Hodgkins Disease", "Hodgkin's Disease", "Multiple Myeloma", "Myelodysplastic Syndrome", "Myeloproliferative Neoplasm"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06693362",
          "briefTitle": "A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Safety and Efficacy of Uterine Blood Mesenchymal Stem Cells Injection for the Treatment of Severe Pneumonia Caused by Viruses"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-01-20",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2028-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Severe Viral Pneumonia(Not Include COVID-19)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06775405",
          "briefTitle": "A Study to Confirm the Effectiveness and Safety of AK0529 in Treating RSV Infections in Hospitalized Infants"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-02-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-09",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Respiratory Synctial Virus Infections"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 180,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "1 Month",
          "maximumAge": "24 Months"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04353180",
          "briefTitle": "Assessment the Activity Value of Isotretinoin (13- Cis-Retinoic Acid ) in the Treatment of COVID-19 ( Isotretinoin in Treatment of COVID-19) (Randomized)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-08",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2021-11",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "COVID19"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 100000,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04570254",
          "briefTitle": "Antioxidants as Adjuvant Therapy to Standard Therapy in Patients With COVID-19"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-08-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-12-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Pneumonia, Viral", "Covid19", "ARDS", "Oxidative Stress"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 110,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05638919",
          "briefTitle": "Real World COVID-19 Antiviral Effectiveness Research"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-12-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-07-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "COVID-19"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 660,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04429529",
          "briefTitle": "Safety of TY027, a Treatment for COVID-19, in Humans"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-06-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-01-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Coronavirus Disease-2019 (COVID-19)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 32,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "21 Years",
          "maximumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04060277",
          "briefTitle": "Triplex Vaccine in Preventing CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplantation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-11-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2030-04-07",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "Acute Lymphoblastic Leukemia", "Acute Myeloid Leukemia", "Chronic Lymphocytic Leukemia", "Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive", "Hematopoietic and Lymphoid Cell Neoplasm", "Hodgkin Lymphoma", "Lymphoblastic Lymphoma", "Myelodysplastic Syndrome", "Myelofibrosis", "Myeloproliferative Neoplasm", "Non-Hodgkin Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 7,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04317040",
          "briefTitle": "Efprezimod Alfa (CD24Fc, MK-7110) as a Non-antiviral Immunomodulator in COVID-19 Treatment (MK-7110-007)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-04-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-10-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Coronavirus Disease 2019 (COVID-19)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 234,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01799486",
          "briefTitle": "Telbivudine Renoprotective Effect in Patients With the HBV-related Liver Cirrhosis: a Randomized Controlled Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-02"
          },
          "completionDateStruct": {
            "date": "2015-03",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "HBV-related Liver Cirrhosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 300,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06160635",
          "briefTitle": "D-SOLVE Cohorts (Cohort a and B)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-02-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-09-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["HDV", "HDV Infection", "Chronic Liver Disease"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 750,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04836299",
          "briefTitle": "Clinical Trial to \"Study the Efficacy and Therapeutic Safety of Ivermectin: (SAINTBO)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-05-08",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2021-12-05",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Covid19"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 90,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03233412",
          "briefTitle": "Randomized Clinical Trial Evaluating the Efficacy of Topical Imiquimod in High Grade Cervical Intraepithelial Lesions"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-01-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-01-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["High Grade Intraepithelial Neoplasia", "Cervix Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 90,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "25 Years",
          "maximumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01231555",
          "briefTitle": "Dose-finding Study of GSK2248761 in Antiretroviral Therapy-Naive Subjects (SIGNET)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-11-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2011-07-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Infection, Human Immunodeficiency Virus"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 23,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04409483",
          "briefTitle": "Evaluation of Additional Treatments for COVID-19: a Randomized Trial in Niger"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-06-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-12-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Covid-19"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04361422",
          "briefTitle": "Isotretinoin in Treatment of COVID-19"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-12-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2021-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "COVID-19"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 300,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03900988",
          "briefTitle": "Intravenous N-acetylcysteine and Oseltamivir Versus Oseltamivir in Adults Hospitalized With Influenza and Pneumonia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-05-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Influenza"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 160,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03621930",
          "briefTitle": "RESCEU Study, Defining the Burden of Disease of RSV in Older Adults"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-08-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-12-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["RSV Infection", "Respiratory Syncytial Virus Infections", "Bronchiolitis"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 1040,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05711810",
          "briefTitle": "Medicine-induced Cardiac Hemodialysis on COVID-19"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-01-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-01-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Severe Acute Respiratory Syndrome-related Coronavirus", "Renal Dialysis", "Vaccines", "Myocarditis Allergic", "Infection Viral"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05046366",
          "briefTitle": "Development of an Artificial Intelligence System for Intelligent Pathological Diagnosis and Therapeutic Effect Prediction Based on Multimodal Data Fusion of Common Tumors and Major Infectious Diseases in the Respiratory System Using Deep Learning Technology."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-10-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Artificial Intelligence", "Deep Learning", "Pathology, Molecular", "Medical Informatics", "Database", "Lung Cancer", "Pulmonary Tuberculosis", "Covid19"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 1000,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "90 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03889028",
          "briefTitle": "Pre-engraftment Cytomegalovirus DNAemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-09-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-09-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "CMV DNAemia Pre-engraftment"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 878,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07254052",
          "briefTitle": "Effectiveness of Ammonium Chloride in Reducing Viral Load"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-09-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-05-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["RNA Virus Infections", "Viral Infection COVID-19", "Influenza A and B"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 32,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04884490",
          "briefTitle": "The Role of High Dose Co-trimoxazole in Severe Covid-19 Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-05-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-11-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "COVID-19 Pneumonia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 94,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01672983",
          "briefTitle": "A Study to Evaluate ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Japanese Adults With Chronic Hepatitis C Virus Infection"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-07"
          },
          "completionDateStruct": {
            "date": "2014-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Hepatitis C Infection"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 110,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05789615",
          "briefTitle": "Letermovir Prophylaxis for CMV Infection in Haplo-HSCT Recipients: Single-center Data in China"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-04-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-01-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["CMV Infection", "Hematopoietic Stem Cell Transplantation"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 200,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04056533",
          "briefTitle": "Prophylaxis of Cytomegalovirus Infection With Adoptive Cell Inmunotherapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-03-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "CMV"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 15,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04536350",
          "briefTitle": "Inhaled Aviptadil for the Treatment of COVID-19 in Patients at High Risk for ARDS"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-05-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-06-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Covid19", "Corona Virus Infection", "ARDS", "Aviptadil"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 83,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00605384",
          "briefTitle": "A Phase IIIb Study to Compare Entecavir Plus Tenofovir vs. Adefovir Added to Continuing Lamivudine Therapy in Adult Patients With Lamivudine-Resistant Hepatitis B Infection"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-08"
          },
          "completionDateStruct": {
            "date": "2009-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Hepatitis B"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 4,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06812598",
          "briefTitle": "Efficacy of Extended Letermovir Prophylaxis to Prevent CMV Reactivation in High-Risk Chinese Adults Undergoing Allogeneic HSCT"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-12-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Cytomegalovirus Infections", "CMV"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 330,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02685930",
          "briefTitle": "Pneumonia in the Intensive Care Unit (ICU) Setting"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-01"
          },
          "completionDateStruct": {
            "date": "2017-02-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Pneumonia", "Respiratory Failure"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 364,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05457556",
          "briefTitle": "Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-03-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Lymphoblastic Leukemia", "Acute Myeloid Leukemia", "Mixed Phenotype Acute Leukemia", "Myelodysplastic Syndrome"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 435,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Months",
          "maximumAge": "21 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05882331",
          "briefTitle": "Extracorporeal Photopheresis as a Possible Therapeutic Approach to Adults With Severe and Critical COVID-19"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-01-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-08-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "COVID-19"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 7,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "100 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04828161",
          "briefTitle": "A Dose Finding, Efficacy and Safety Study of Ensovibep (MP0420) in Ambulatory Adult Patients With Symptomatic COVID-19"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-05-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-01-27",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "COVID-19"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 407,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04358380",
          "briefTitle": "Liver Injury in Patients With COVID-19"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-04-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Liver Injury"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 320,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00391313",
          "briefTitle": "CuraChik : A Trial of the Efficacy and Safety of Chloroquine as Therapeutic Treatment of Chikungunya Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-05"
          },
          "completionDateStruct": {
            "date": "2007-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Chikungunya Virus"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {}
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "66 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00163657",
          "briefTitle": "Study of Liver Transplant For End-Stage Liver Disease Caused By Chronic Hepatitis C Infection"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2002-07"
          },
          "completionDateStruct": {
            "date": "2007-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["End Stage Liver Disease", "Hepatitis C"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 312,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05780541",
          "briefTitle": "PF-07304814 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-09-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-07-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "COVID-19"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 58,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02126137",
          "briefTitle": "Pilot Study of Ezetimibe for Chronic Hepatitis C Virus (HCV) Infection"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-10"
          },
          "completionDateStruct": {
            "date": "2016-03",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Hepatitis C"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04393051",
          "briefTitle": "Baricitinib Compared to Standard Therapy in Patients With COVID-19"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-05-20",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2020-07-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Covid-19", "SARS-CoV 2", "SARS Pneumonia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 126,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03887702",
          "briefTitle": "Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid Tumors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-01-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-12-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Hepatitis B Infection", "Malignant Solid Neoplasm"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 4,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03238612",
          "briefTitle": "Flufenamic Acid for Hospitalised Influenza Infection"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-01-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-10-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Influenza A"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 200,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03683329",
          "briefTitle": "Antibiotic De-escalation in Onco-hematology Patients for Sepsis or Septic Shock"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-11-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-04",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Critical Care", "Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 466,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04361461",
          "briefTitle": "Use of Hydroxychloroquine Alone or Associated for Inpatients With SARS-CoV2 Virus (COVID-19)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-04-30",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2020-11-04",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Coronavirus Infections", "SARS-CoV 2", "SARS (Severe Acute Respiratory Syndrome)", "Pulmonary Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05076253",
          "briefTitle": "Efficacy of Ivermectin in COVID-19"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-09-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-12-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Safety", "SARS-CoV2 Infection", "Ivermectin Poisoning", "Effect of Drug"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 72,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05814237",
          "briefTitle": "POS-ARI-ER Observational Study of Acute Respiratory Infections"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-06-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-02-28",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Respiratory Infection", "Acute Respiratory Tract Infection"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 11750,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03437876",
          "briefTitle": "Study on Effect of Intestinal Microbiota Transplantation in Hepatitis B Virus Induced Cirrhosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-10-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Cirrhosis, Liver"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04596839",
          "briefTitle": "Antiviral Activity and Safety of Remdesivir in Bangladeshi Patients With Severe Coronavirus Disease (COVID-19)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-09-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-04-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Covid19"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04342169",
          "briefTitle": "University of Utah COVID-19 Hydrochloroquine Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-04-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-11-15",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Coronavirus Infection", "Coronavirus", "Infectious Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 368,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04385095",
          "briefTitle": "Trial of Inhaled Anti-viral (SNG001) for SARS-CoV-2 (COVID-19) Infection"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-03-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-11-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "SARS-CoV-2"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 221,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05780281",
          "briefTitle": "VIR-7831 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-12-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-10-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "COVID-19"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 367,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00071799",
          "briefTitle": "A Survival Study in Patients With High Risk Myelodysplastic Syndromes Comparing Azacitidine Versus Conventional Care"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2003-11-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2007-07-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Myelodysplastic Syndromes"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 358,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06211543",
          "briefTitle": "Letermovir (LMV) Prophylaxis in CMV-seronegative Allogeneic Stem Cell Transplant Recipients With CMV Seropositive Donors: an Exploratory Study From Spanish GETH/TC Centers"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-03-30",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-03-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "CMV"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 80,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05305547",
          "briefTitle": "A Study to Compare S-217622 With Placebo in Non-Hospitalized Participants With COVID-19"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-08-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-05-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "SARS-CoV-2 Infection"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2093,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02986802",
          "briefTitle": "Comparative Effectiveness of Treatment Options for Genital Herpes Infection to Reduce Adverse Pregnancy Outcomes"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-03-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-02-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["HSV-2 Infection", "PreTerm Birth", "Pregnancy Complications"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 89132,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03331445",
          "briefTitle": "Inhaled Gaseous Nitric Oxide (gNO) Antimicrobial Treatment of Difficult Bacterial and Viral Lung (COVID-19) Infections"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-10-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-06-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Respiratory Tract Infections", "Corona Virus Infection"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 13,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "19 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02439567",
          "briefTitle": "Transient Elastography to Assess Liver Fibrosis and Portal Hypertension in HCV Cirrhotic Patients Treated With New Antiviral Drugs (SPLEEN-C)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-01"
          },
          "completionDateStruct": {
            "date": "2016-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Chronic Hepatitis C", "Cirrhosis", "Portal Hypertension"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 41,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "90 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04402203",
          "briefTitle": "Study on Safety and Efficacy of Favipiravir (Favipira) for COVID-19 Patient in Selected Hospitals of Bangladesh"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-05",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2020-07",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["COVID-19", "Favipiravir (Favipira)"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04466241",
          "briefTitle": "Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-11-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-11-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["COVID-19", "COVID-19 Drug Treatment", "Severe Acute Respiratory Syndrome Coronavirus 2"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 294,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07120750",
          "briefTitle": "Post-Radical Treatment Antiviral Strategies in HBV-Related Liver Cancer: Impact on Tumor Prognosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-09-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2030-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Hepatocellular Carcinoma (HCC)", "Chronic Hepatitis B"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 332,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04808895",
          "briefTitle": "Acetylsalicylic Acid in the Prevention of Severe SARS-CoV2 Pneumonia in Hospitalised Patients With COVID-19"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-04-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2021-08-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["COVID-19", "Thrombosis Pulmonary"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 204,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07087041",
          "briefTitle": "A Study to Predict Recompensation in Patients With Decompensated Cirrhosis Using Spleen Stiffness and Simple Blood Tests"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-07-15",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2028-12-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Decompensated Cirrhosis", "Hepatitis B Virus (HBV) Infection", "Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)", "Alcohol-Related Liver Disease", "Portal Hypertension", "Recompensation"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 735,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04331600",
          "briefTitle": "Chloroquine as Antiviral Treatment in Coronavirus Infection 2020"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-04-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-12-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "COVID-19"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 16,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02108522",
          "briefTitle": "Multivirus-specific T Cells for the Treatment of Virus Infections After Stem Cell Transplant"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-06"
          },
          "completionDateStruct": {
            "date": "2019-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Infection"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 82,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03083756",
          "briefTitle": "Validation of a Risk Score Opportunistic Infections Development in Kidney Transplant Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-08"
          },
          "completionDateStruct": {
            "date": "2017-02-15",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Opportunistic Infections"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 577,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06955559",
          "briefTitle": "Magnesium Sulfate in Bronchial Asthma and Acute Bronchiolitis in Children"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-05-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-08-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Asthma in Children"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "1 Month",
          "maximumAge": "18 Years"
        }
      }
    ],
    "protocolSection.2": [
      {
        "identificationModule": {
          "nctId": "NCT05938647",
          "briefTitle": "Severe Dengue in Critical Care at Villavicencio, Colombia."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-07-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Severe Dengue"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "120 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02393365",
          "briefTitle": "Prevalence and Screening of Hepatitis C in Belgium in 2015"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-03-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-12-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hepatitis C"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 10000,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "80 Years",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06679140",
          "briefTitle": "A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-12-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-05-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "COVID-19 SARS-CoV-2 Infection"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2330,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02287467",
          "briefTitle": "Evaluating the Safety and Efficacy of Anti-Influenza Intravenous Hyperimmune Immunoglobulin (IVIG) in Adults Hospitalized With Influenza"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-01"
          },
          "completionDateStruct": {
            "date": "2018-06-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Influenza A", "Influenza B"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 329,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00985582",
          "briefTitle": "Antiviral Therapy for Influenza A H1N1"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-09"
          },
          "completionDateStruct": {
            "date": "2010-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Influenza A Virus Infection"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 181,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "1 Year"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05325008",
          "briefTitle": "A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-08-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["BK Viremia", "Kidney Transplant Infection", "Kidney Transplant Failure and Rejection"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 280,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05317260",
          "briefTitle": "Steatohepatitis in Chronic Hepatitis B"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2002-01-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-12-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Fatty Liver", "Chronic Hepatitis b"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 408,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05370976",
          "briefTitle": "Efficacy and Safety of CytotectÂ®CP, Hyperimmune Anti-CMV IVIg as CMV Prophylaxis in Patients Developing Acute Grade II-IV GVHD After Allogeneic Hematopoietic Cell Transplantation."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-09-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-08-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cytomegalovirus Infections"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06999603",
          "briefTitle": "Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-09-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-05",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Viral Pneumonia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 550,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01227798",
          "briefTitle": "Safety and Efficacy Study of Interferon to Treat Patients Hospitalized for Influenza"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-11"
          },
          "completionDateStruct": {
            "date": "2011-11",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Influenza"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "70 Years",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04409522",
          "briefTitle": "Evaluation of Therapeutic Effects of Melatonin by Inhibition of NLRP3 Inflammasome in COVID19 Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-05-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-09-25",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "COVID-19"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 55,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "100 Years",
          "minimumAge": "16 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05780437",
          "briefTitle": "AZD7442 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-02-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-06-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "COVID-19"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1455,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03429439",
          "briefTitle": "Study on Effect of Intestinal Microbiota Transplantation in Chronic Hepatitis B"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-12-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-11",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Hepatitis b"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "65 Years",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05822583",
          "briefTitle": "Strategies and Treatments for Respiratory Infections &Amp; Viral Emergencies (STRIVE): Immune Modulation Strategy Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-07-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-08-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "COVID-19"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 285,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04558424",
          "briefTitle": "RCT,Double Blind, Placebo to Evaluate the Effect of Zinc and Ascorbic Acid Supplementation in COVID-19 Positive Hospitalized Patients in BSMMU"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-10-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2021-09-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Covid19"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "70 Years",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04351724",
          "briefTitle": "Austrian CoronaVirus Adaptive Clinical Trial (COVID-19)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-04-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-03-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "COVID-19"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 500,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "maximumAge": "99 Years",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03524794",
          "briefTitle": "HepCare: The Effectiveness of Community Based Interventions With Peer Support to Improve Case Detection, Carry Out Pre-treatment Assessments and Assist Underserved Populations Through HCV Treatment"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-08-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-03-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Hepatitis C", "Infectious Disease"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 164,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "16 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05284916",
          "briefTitle": "Difference in Patterns of Liver Diseases Related Admissions After the Era of DAAS"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-03-15",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2022-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Patternsof Liver Diseasesadmissions After Era of DAAS"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 200,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00101374",
          "briefTitle": "Effect of Leflunomide on T Cell Proliferation in HIV-Infected Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2005-01-05"
          },
          "completionDateStruct": {
            "date": "2008-05-21",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "HIV Infections"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 41,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "65 Years",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04390594",
          "briefTitle": "Efficacy and Safety Evaluation of Treatment Regimens in Adult COVID-19 Patients in Senegal"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-08-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-02-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "COVID-19"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 59,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03278444",
          "briefTitle": "Treatment of Advanced Hepatocellular Carcinoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-07-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-07",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "HCC"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 300,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "65 Years",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07197164",
          "briefTitle": "Safety and Effectiveness of a Remdesivir Treatment to Prevent Severe COVID-19 in Kidney Transplant Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-09-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-02-28",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["COVID - 19", "Renal Transplant", "SARS CoV 2 Infection"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 15,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04362332",
          "briefTitle": "Chloroquine, Hydroxychloroquine or Only Supportive Care in Patients AdmItted With Moderate to Severe COVID-19"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-04-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-06-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "COVID-19"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 25,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "maximumAge": "110 Years",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02957136",
          "briefTitle": "Rapid Diagnostics for Upper Respiratory Infections in the Emergency Department"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-12-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-04-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Respiratory Tract Infections", "Influenza, Human", "Common Cold"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 194,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "101 Years",
          "minimumAge": "1 Year"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06896253",
          "briefTitle": "Pulse Corticosteroids Or/and Immunoglobulins to Treat Fulminant Myocarditis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-04",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2029-11",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Myocarditis Acute"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 120,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "15 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04056611",
          "briefTitle": "Effects of JNJ-53718678 in Adult and Adolescent Participants Who Had a Hematopoietic Stem Cell Transplantation and Who Are Infected With Respiratory Syncytial Virus (RSV)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-12-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-02-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Respiratory Syncytial Virus Infections"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 3,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "75 Years",
          "minimumAge": "13 Years"
        }
      }
    ]
  }
}
